研究與發展
為我們的患者工作
我們的研究與發展團隊致力於發現、開發和提供可能改變患者生活的藥物，並在高度未滿足的需求領域建立新的照護標準。我們正在創造改變人生的藥物，用以消除世界上一些最棘手病症：癌症、心臟和免疫系統疾病以及血液疾病。工作內容並不容易，但所做的事獨特又有趣。您將改寫規則、解決最艱難的挑戰，並創造奇蹟。
Explore careers in Research & Development
我們對於自己在腫瘤學、血液學、免疫學、心血管學和神經科學等核心治療領域取得的進展感到自豪。 我們多元化和具前瞻性的研發項目專注於治療領域的研究，我們相信很有機會在該領域為患者提供變革型藥物。在開發改變生命的新一代突破性療法方面，BMS 是您最佳的選擇。您將體驗到有趣的工作、令人振奮的職涯成長，以及在各自領域中處於領導地位的優秀隊友。這可能會改變您的職涯。
Our next neuroscience breakthrough need authors
Neurological and neuropsychiatric conditions are complex and present significant challenges in healthcare today. These disorders are often long-lasting and difficult to treat, causing a major impact on patients, caregivers, and families.
At Bristol Myers Squibb, you will be part of a team working to address some of the toughest neurological issues, creating real change for those affected. Our mission is to lead in innovation by developing new treatments that can slow the progress of these diseases and improve quality of life for patients and those who support them.
Discover the innovation of RayzeBio.
RayzeBio is a dynamic biotechnology company headquartered in San Diego, CA. Launched in late 2020 and recently acquired by Bristol Myers Squibb (BMS) as a wholly owned subsidiary, the company is focused on improving survival of people with cancer by harnessing the power of targeted radioisotopes.
RayzeBio will operate as a standalone entity within the BMS organization, maintaining its biotech culture with the opportunity to leverage the best-in-class oncology capabilities of BMS. RayzeBio is developing innovative drugs against targets of solid tumors.
English 
Japanese 
French 
German 
Italian 
Korean 
Portuguese 
Chinese (China) 
Spanish 
Chinese (Taiwan) 
